Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 327.88% and Operating profit at -352.66% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Negative results in Sep 25
3
Risky -
Stock DNA
Commercial Services & Supplies
USD 5,351 Million (Small Cap)
8.00
NA
0.00%
-0.33
-999,999.00%
-4.74
Revenue and Profits:
Net Sales:
115 Million
(Quarterly Results - Mar 2026)
Net Profit:
-342 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
46.01%
0%
46.01%
6 Months
71.49%
0%
71.49%
1 Year
133.24%
0%
133.24%
2 Years
508.67%
0%
508.67%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Core Scientific, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
327.88%
EBIT Growth (5y)
-352.66%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
-4.74
EV to EBIT
-30.45
EV to EBITDA
-59.68
EV to Capital Employed
-7.62
EV to Sales
17.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 70 Schemes (28.16%)
Foreign Institutions
Held by 171 Foreign Institutions (19.6%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
115.20
79.80
44.36%
Operating Profit (PBDIT) excl Other Income
-3.90
-22.10
82.35%
Interest
4.90
0.90
444.44%
Exceptional Items
-304.30
261.50
-216.37%
Consolidate Net Profit
-342.40
190.50
-279.74%
Operating Profit Margin (Excl OI)
-206.00%
-491.90%
28.59%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 44.36% vs -1.60% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -279.74% vs 231.47% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
319.00
510.70
-37.54%
Operating Profit (PBDIT) excl Other Income
-112.80
108.90
-203.58%
Interest
0.00
37.10
-100.00%
Exceptional Items
-88.60
-1,387.00
93.61%
Consolidate Net Profit
-280.70
-1,245.30
77.46%
Operating Profit Margin (Excl OI)
-604.80%
-21.90%
-58.29%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -37.54% vs 1.65% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 77.46% vs -405.19% in Dec 2024






